Stock listing

Mindbio Therapeutics Corp.

Selected listing: MBIO · CSE · CAD · CA

Mindbio Therapeutics Corp. (CSE:MBIO), Health Technology. Latest release May 11, 2026: MindBio Develops Fatigue Prediction Model using Speech Analytics and AI.

MBIO:CSECADCAUpdated October 2, 2026

Ticker: CSE:MBIO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: CSE
Currency: CAD

About Mindbio Therapeutics Corp.

Mindbio Therapeutics Corp. (Ticker: MBIO) is a public company based in Canada, focused on the development of innovative therapeutic solutions. Mindbio is dedicated to addressing unmet medical needs through its unique approach to treatment development.

Latest news from Mindbio Therapeutics Corp.

MindBio Develops Fatigue Prediction Model using Speech Analytics and AI

May 11, 2026

MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI

May 5, 2026

MindBio Files Patent Applications in 15 World Firsts

April 29, 2026

MindBio Appoints Market Maker Venture Liquidity Providers

April 13, 2026

MindBio Announces Closing of Private Placement

April 1, 2026

All Mindbio Therapeutics Corp. news →

Research Mindbio Therapeutics Corp.

Mindbio Therapeutics Corp. company profile

View the public company page for Mindbio Therapeutics Corp. on 6ix.

Mindbio Therapeutics Corp. news

Read company news and market updates connected to Mindbio Therapeutics Corp..

Mindbio Therapeutics Corp. investor events

Find investor webinars, events, and replay context for Mindbio Therapeutics Corp..